Market Place
Sourcing Support
FDA Confirms Para IV Patent Litigation for Crextont Capsules
03 Dec 2024 //
FDA
Avion Pharma`s Dhivy® and advocateJoins Rock Steady Boxing Event
03 Oct 2024 //
PR NEWSWIRE
Amneal Launches CREXONT For Parkinson`s Disease Treatment
23 Sep 2024 //
BUSINESSWIRE
Amneal Receives FDA Approval For CREXONT To Treat Parkinson`s Disease
07 Aug 2024 //
BUSINESSWIRE
US FDA rejects AbbVie`s Parkinson`s disease therapy for the second time
26 Jun 2024 //
FIERCE PHARMA
BioVie Presents Protocol Design for SUNRISE-PD Trial at ATMRD 2024
25 Jun 2024 //
GLOBENEWSWIRE
Rubicon`s Generic Carbidopa; Levodopa Receives Approval in US
04 Jun 2024 //
FDA
Acorda and Merz Announce Signing of “Stalking Horse” Asset Purchase Agreement
01 Apr 2024 //
BUSINESSWIRE
Beximco Pharma`s Generic Carbidopa Receives Approval in the U.S.
11 Dec 2023 //
FDA
Mitsubishi Tanabe Pharma America Presents Positive Results from Pivotal Phase 3
29 Aug 2023 //
PR NEWSWIRE
JAMA Publishes Phase 3 Study Results Comparing IPX203 to Carbidopa/Levodopa
24 Aug 2023 //
BUSINESSWIRE
Zydus` Generic Carbidopa, Levodopa Approval in the U.S.
04 Apr 2023 //
FDA
Sandoz`s Generic Carbidopa, Levodopa Receives Approval in the U.S.
31 Mar 2023 //
FDA
US FDA declines to approve AbbVie`s Parkinson`s disease therapy
23 Mar 2023 //
HEALTH ET
Enforcement Report - Week of March 8, 2023
08 Mar 2023 //
FDA
Aurobindo`s Generic Carbidopa, Levodopa Receives Approval in the U.S.
28 Nov 2022 //
FDA
Rubicon`s Generic Carbidopa, Levodopa Receives Approval in the U.S.
21 Sep 2022 //
FDA
BeyoND Phase 2b Data Indicates ND0612 Has Long-Term Safety Profile in PD
04 Apr 2022 //
PRNEWSWIRE
Avion Pharma announces FDA approval and availability of DHIVY for Parkinson`s
14 Feb 2022 //
PRNEWSWIRE
AbbVie Eyes Potential Approval for Parkinson’s Treatment after +ve results
28 Oct 2021 //
BIOSPACE
ScieGen Pharma`s Generic Carbidopa;Levodopa Receives Approval in US
07 Oct 2021 //
FDA
Amneal’s IPX-203 shows promising results for motor fluctuations in PD
08 Sep 2021 //
PHARMAFILE
Amneal touts results of PIII Parkinson`s trial; NovaRock partners on cancer drug
26 Aug 2021 //
ENDPTS
Sciegen Pharms Generic Carbidopa Levodopa Receives Approval In US
12 May 2021 //
FDA
AbbVie to Present New Data of Parkinson`s Disease and Movement Disorders
11 Sep 2020 //
PRNNEWSWIRE
Mylan Pharms`s Carbidopa;Entacapone;LevodopaTentative Approval in US
19 Aug 2020 //
FDA
Zydus Pharms`s Generic Levodopa;Carbidopa Receives Tentative Approval in US
31 Jul 2020 //
FDA
Morton Grove`s Withdrawal of Approval of 21 Abbreviated New Drug Applications
02 Dec 2019 //
FEDERALREGISTER
Lobsor Pharma receives Japanese patent for APD solution
31 Oct 2019 //
BIOSPECTRUMASIA
Lobsor Pharma receives Japanese patent for APD solution
30 Oct 2019 //
BIOSPECTRUMASIA
Aurobindo Pharma`s Generic Carbidopa Receives Approval in US
23 Oct 2019 //
FDA
Kyowa Kirin Announces NOURIANZ™ (Istradefylline) Now Available in the U.S.
14 Oct 2019 //
BUSINESSWIRE
Mitsubishi Tanabe Announces Presentation of Patient-Reported Result ph 2 ND0612
23 Sep 2019 //
PR NEWSWIRE
HiFiBiO`s Kite-backed C round; Kyowa Kirin`s Parkinson`s nod; Relief for Sun
30 Aug 2019 //
FIERCE PHARMA
FDA review finds no increased risk of prostate cancer Comtan, Stalevo
13 Aug 2019 //
FDA
Intec flunks phase 3 Parkinson`s test against Merck drug
23 Jul 2019 //
FIERCE BIOTECH
Intec Pharma Announces Results from Phase 2 Clinical Trial of Accordion Pill
25 Jun 2019 //
BIOSPACE
Alembic Pharma gets USFDA nod for Parkinson`s disease treatment drugs
07 Jun 2019 //
ECONOMIC TIMES
Acorda Therapeutics Announces FDA Approves INBRIJA™ (levodopa inhalation powder)
28 Dec 2018 //
BUSINESSWIRE
Merck runs out of Parkinson’s disease drug Sinemet as manufacturing issues
04 Oct 2018 //
FIERCE PHARMA
Duke startup Evecxia brings on ex-Cerecor chief as CEO
16 Aug 2018 //
FIERCE BIOTECH
Merck’s price cuts are flashy, but no more benevolent than Pfizer’s freeze
20 Jul 2018 //
FIERCE PHARMA
Amneal Announces Patent Litigation Settlement Agreement with Actavis Rytary®
20 Jun 2018 //
PR NEWSWIRE
Rytary® (Levodopa/Carbidopa) Capsules: Impax Lab, v. Actavis Laboratories
17 May 2018 //
PATENT LITIGATION
Zydus Pharms USA Generic Carbidopa Receives Approval In US
09 May 2018 //
FDA
Intec`s Presented Phase 1 PK and Safety Data - Accordion Pill Carbidopa/Levodopa
24 Apr 2018 //
PR NEWSWIRE
Lupin brings generic Lodosyn tablets to US market
27 Mar 2018 //
BIOSPECTRUM
Intec Pharma-LTS Manufacture of Carbidopa/Levodopa for Parkinson`s Disease
12 Mar 2018 //
PRNEWS WIRE
Intec Pharma acknowledged with patent
09 Jan 2018 //
BIOSPECTRUM
Intec gets Canadian patent for Accordion Pill controlled release tech
04 Jan 2018 //
IN PHARMATECHNOLOGIST
Novel Lab’s Generic Carbidopa Receives Approval In US
22 Oct 2017 //
FDA
Parkinson’s disease drug carbidopa shows anticancer effects
29 Sep 2017 //
EU PHARMACEUTICAL
Rytary® (Levodopa/Carbidopa): Impax Laboratories, Inc. V. Actavis Laboratories
09 May 2017 //
PATENT LITIGATION
FDA OK’s first novel treatment for Parkinson’s in ten years
22 Mar 2017 //
PHARMA TIMES
Enforcement Report - Week of March 8, 2017
08 Mar 2017 //
FDA
Acorda Inhaled Drug Reduces Parkinson`s Motor Symptoms in Late-Stage Study
10 Feb 2017 //
THE STREET
After delay, ISCO`s trial of Parkinson`s stem cell therapy gets underway again
16 Dec 2016 //
FIERCE BIOTECH
